Kevin Warsh's nomination hearing tomorrow could define the Fed's path on its $9tn balance sheet, now 35% of GDP. Warsh advocates shrinking it, citing distortions from past quantitative easing. His stance contrasts with the Fed's recent $200bn expansion via reserve management purchases, driven by liquidity fears after the 2019 "repocalypse."

The balance sheet debate isn't new. Before 2008, it was 6% of GDP. Post-crisis, aggressive QE ballooned it. Warsh argues active sales or regulatory tweaks could normalize it. Dallas Fed president Lorie Logan and others propose altering liquidity rules to reduce banks' reserve demand. Yet practical steps remain unclear. The Fed's balance sheet grew again last year, raising questions about whether it will prioritize market stability or political messaging.

Markets watch Warsh's signals closely. A hardline balance sheet reduction could spike borrowing costs, while inaction risks perpetuating fiscal policy overreach. Treasury secretary Scott Bessent has criticized QE as "gain of function monetary policy," highlighting political tensions. The core conflict isn't just theoretical—it impacts real asset prices and corporate borrowing costs. Investors need clarity on whether the Fed will "do a Bank of England" with active sales or let the balance sheet shrink organically.